Nivolumab in non-small-cell lung cancer with EGFR mutation
Gespeichert in:
| Veröffentlicht in: | Annals of oncology 2018-03, Vol.29 (3), p.777-778 |
|---|---|
| Hauptverfasser: | , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 778 |
|---|---|
| container_issue | 3 |
| container_start_page | 777 |
| container_title | Annals of oncology |
| container_volume | 29 |
| creator | Yoshida, H. Kim, Y.H. Ozasa, H. Nagai, H. Sakamori, Y. Tsuji, T. Nomizo, T. Yasuda, Y. Funazo, T. Hirai, T. |
| description | |
| doi_str_mv | 10.1093/annonc/mdx745 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1967465436</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><oup_id>10.1093/annonc/mdx745</oup_id><els_id>S0923753419354869</els_id><sourcerecordid>1967465436</sourcerecordid><originalsourceid>FETCH-LOGICAL-c413t-c997bcf15d5bdef754b34ee92bf2fb2ea8c35506c43e58296225019fb30d4d243</originalsourceid><addsrcrecordid>eNqFkD1PwzAQQC0EoqUwsqKMLKH-Ts2GqrYgVSAhmC3HuYBRYpc4KfDvSRU-JsR0y7t3p4fQKcEXBCs2Nd4Hb6d18Z5xsYfGREiVzjAn-2iMFWVpJhgfoaMYXzDGUlF1iEZUEUmYyMbo8tZtQ9XVJk-cT3pVGmtTVamFqkqqzj8l1ngLTfLm2udksVreJ3XXmtYFf4wOSlNFOPmaE_S4XDzMr9P13epmfrVOLSesTa1SWW5LIgqRF1BmgueMAyial7TMKZiZZUJgaTkDMaNKUiowUWXOcMELytkEnQ_eTRNeO4itrl3c_Wc8hC5qomTGpeBM9mg6oLYJMTZQ6k3jatN8aIL1LpcecukhV8-ffam7vIbih_7u83s7dJt_XdmAQt9i66DR0Tro2xWuAdvqIrg_Nj8BNNuIxA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1967465436</pqid></control><display><type>article</type><title>Nivolumab in non-small-cell lung cancer with EGFR mutation</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Yoshida, H. ; Kim, Y.H. ; Ozasa, H. ; Nagai, H. ; Sakamori, Y. ; Tsuji, T. ; Nomizo, T. ; Yasuda, Y. ; Funazo, T. ; Hirai, T.</creator><creatorcontrib>Yoshida, H. ; Kim, Y.H. ; Ozasa, H. ; Nagai, H. ; Sakamori, Y. ; Tsuji, T. ; Nomizo, T. ; Yasuda, Y. ; Funazo, T. ; Hirai, T.</creatorcontrib><identifier>ISSN: 0923-7534</identifier><identifier>EISSN: 1569-8041</identifier><identifier>DOI: 10.1093/annonc/mdx745</identifier><identifier>PMID: 29161357</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Adult ; Aged ; Antineoplastic Agents, Immunological - therapeutic use ; Carcinoma, Non-Small-Cell Lung - drug therapy ; Carcinoma, Non-Small-Cell Lung - genetics ; ErbB Receptors - genetics ; Female ; Humans ; Lung Neoplasms - drug therapy ; Lung Neoplasms - genetics ; Male ; Middle Aged ; Mutation ; Nivolumab - therapeutic use</subject><ispartof>Annals of oncology, 2018-03, Vol.29 (3), p.777-778</ispartof><rights>2017 THE AUTHORS</rights><rights>The Author 2017. Published by Oxford University Press on behalf of the European Society for Medical Oncology. All rights reserved. For Permissions, please email: journals.permissions@oup.com. 2017</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c413t-c997bcf15d5bdef754b34ee92bf2fb2ea8c35506c43e58296225019fb30d4d243</citedby><cites>FETCH-LOGICAL-c413t-c997bcf15d5bdef754b34ee92bf2fb2ea8c35506c43e58296225019fb30d4d243</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29161357$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yoshida, H.</creatorcontrib><creatorcontrib>Kim, Y.H.</creatorcontrib><creatorcontrib>Ozasa, H.</creatorcontrib><creatorcontrib>Nagai, H.</creatorcontrib><creatorcontrib>Sakamori, Y.</creatorcontrib><creatorcontrib>Tsuji, T.</creatorcontrib><creatorcontrib>Nomizo, T.</creatorcontrib><creatorcontrib>Yasuda, Y.</creatorcontrib><creatorcontrib>Funazo, T.</creatorcontrib><creatorcontrib>Hirai, T.</creatorcontrib><title>Nivolumab in non-small-cell lung cancer with EGFR mutation</title><title>Annals of oncology</title><addtitle>Ann Oncol</addtitle><subject>Adult</subject><subject>Aged</subject><subject>Antineoplastic Agents, Immunological - therapeutic use</subject><subject>Carcinoma, Non-Small-Cell Lung - drug therapy</subject><subject>Carcinoma, Non-Small-Cell Lung - genetics</subject><subject>ErbB Receptors - genetics</subject><subject>Female</subject><subject>Humans</subject><subject>Lung Neoplasms - drug therapy</subject><subject>Lung Neoplasms - genetics</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Mutation</subject><subject>Nivolumab - therapeutic use</subject><issn>0923-7534</issn><issn>1569-8041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkD1PwzAQQC0EoqUwsqKMLKH-Ts2GqrYgVSAhmC3HuYBRYpc4KfDvSRU-JsR0y7t3p4fQKcEXBCs2Nd4Hb6d18Z5xsYfGREiVzjAn-2iMFWVpJhgfoaMYXzDGUlF1iEZUEUmYyMbo8tZtQ9XVJk-cT3pVGmtTVamFqkqqzj8l1ngLTfLm2udksVreJ3XXmtYFf4wOSlNFOPmaE_S4XDzMr9P13epmfrVOLSesTa1SWW5LIgqRF1BmgueMAyial7TMKZiZZUJgaTkDMaNKUiowUWXOcMELytkEnQ_eTRNeO4itrl3c_Wc8hC5qomTGpeBM9mg6oLYJMTZQ6k3jatN8aIL1LpcecukhV8-ffam7vIbih_7u83s7dJt_XdmAQt9i66DR0Tro2xWuAdvqIrg_Nj8BNNuIxA</recordid><startdate>201803</startdate><enddate>201803</enddate><creator>Yoshida, H.</creator><creator>Kim, Y.H.</creator><creator>Ozasa, H.</creator><creator>Nagai, H.</creator><creator>Sakamori, Y.</creator><creator>Tsuji, T.</creator><creator>Nomizo, T.</creator><creator>Yasuda, Y.</creator><creator>Funazo, T.</creator><creator>Hirai, T.</creator><general>Elsevier Ltd</general><general>Oxford University Press</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201803</creationdate><title>Nivolumab in non-small-cell lung cancer with EGFR mutation</title><author>Yoshida, H. ; Kim, Y.H. ; Ozasa, H. ; Nagai, H. ; Sakamori, Y. ; Tsuji, T. ; Nomizo, T. ; Yasuda, Y. ; Funazo, T. ; Hirai, T.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c413t-c997bcf15d5bdef754b34ee92bf2fb2ea8c35506c43e58296225019fb30d4d243</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Antineoplastic Agents, Immunological - therapeutic use</topic><topic>Carcinoma, Non-Small-Cell Lung - drug therapy</topic><topic>Carcinoma, Non-Small-Cell Lung - genetics</topic><topic>ErbB Receptors - genetics</topic><topic>Female</topic><topic>Humans</topic><topic>Lung Neoplasms - drug therapy</topic><topic>Lung Neoplasms - genetics</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Mutation</topic><topic>Nivolumab - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yoshida, H.</creatorcontrib><creatorcontrib>Kim, Y.H.</creatorcontrib><creatorcontrib>Ozasa, H.</creatorcontrib><creatorcontrib>Nagai, H.</creatorcontrib><creatorcontrib>Sakamori, Y.</creatorcontrib><creatorcontrib>Tsuji, T.</creatorcontrib><creatorcontrib>Nomizo, T.</creatorcontrib><creatorcontrib>Yasuda, Y.</creatorcontrib><creatorcontrib>Funazo, T.</creatorcontrib><creatorcontrib>Hirai, T.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yoshida, H.</au><au>Kim, Y.H.</au><au>Ozasa, H.</au><au>Nagai, H.</au><au>Sakamori, Y.</au><au>Tsuji, T.</au><au>Nomizo, T.</au><au>Yasuda, Y.</au><au>Funazo, T.</au><au>Hirai, T.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Nivolumab in non-small-cell lung cancer with EGFR mutation</atitle><jtitle>Annals of oncology</jtitle><addtitle>Ann Oncol</addtitle><date>2018-03</date><risdate>2018</risdate><volume>29</volume><issue>3</issue><spage>777</spage><epage>778</epage><pages>777-778</pages><issn>0923-7534</issn><eissn>1569-8041</eissn><cop>England</cop><pub>Elsevier Ltd</pub><pmid>29161357</pmid><doi>10.1093/annonc/mdx745</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0923-7534 |
| ispartof | Annals of oncology, 2018-03, Vol.29 (3), p.777-778 |
| issn | 0923-7534 1569-8041 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1967465436 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
| subjects | Adult Aged Antineoplastic Agents, Immunological - therapeutic use Carcinoma, Non-Small-Cell Lung - drug therapy Carcinoma, Non-Small-Cell Lung - genetics ErbB Receptors - genetics Female Humans Lung Neoplasms - drug therapy Lung Neoplasms - genetics Male Middle Aged Mutation Nivolumab - therapeutic use |
| title | Nivolumab in non-small-cell lung cancer with EGFR mutation |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T08%3A09%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Nivolumab%20in%20non-small-cell%20lung%20cancer%20with%20EGFR%20mutation&rft.jtitle=Annals%20of%20oncology&rft.au=Yoshida,%20H.&rft.date=2018-03&rft.volume=29&rft.issue=3&rft.spage=777&rft.epage=778&rft.pages=777-778&rft.issn=0923-7534&rft.eissn=1569-8041&rft_id=info:doi/10.1093/annonc/mdx745&rft_dat=%3Cproquest_cross%3E1967465436%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1967465436&rft_id=info:pmid/29161357&rft_oup_id=10.1093/annonc/mdx745&rft_els_id=S0923753419354869&rfr_iscdi=true |